Extracellular Vesicle Isolation Using Polycation and Polymer Precipitation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for isolating extracellular vesicles (EVs) from biological fluid samples are inefficient, often damage the vesicles, and require expensive equipment, making it difficult to recover sufficient amounts from small samples while also dealing with contamination and integrity issues.

Innovation Solution

A method involving the use of a polycationic substance like protamine in combination with an extracellular matrix forming polymer, such as PEG, to precipitate EVs without the need for ultracentrifugation, facilitating efficient recovery and maintaining biological activity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If differential ultracentrifugation is used to isolate EVs, then purification efficiency is improved, but EV integrity is damaged and equipment cost increases

Engineering Contradiction:
Improvepurification efficiencyVSAvoidEV integrity
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent replaces the mechanical ultracentrifugation system with a chemical precipitation system using PEG and protamine. Instead of using high-speed rotation and centrifugal force to separate EVs, the invention uses polymeric precipitation to form a mesh-like net that embeds EVs, thereby avoiding shear stress and mechanical damage while achieving efficient isolation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention changes the isolation parameters from mechanical force-based (centrifugal force, g force, rotor type) to chemical composition-based (PEG concentration, protamine concentration, molecular weight). This parameter change allows efficient EV isolation without the damaging effects of ultracentrifugation.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If differential ultracentrifugation is used to isolate EVs, then purification efficiency is improved, but equipment cost and complexity increase

Engineering Contradiction:
Improvepurification efficiencyVSAvoidequipment requirement
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent replaces the mechanical ultracentrifugation system with a chemical precipitation system using PEG and protamine. Instead of using high-speed rotation and centrifugal force to separate EVs, the invention uses polymeric precipitation to form a mesh-like net that embeds EVs, thereby avoiding shear stress and mechanical damage while achieving efficient isolation.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention uses inexpensive chemical reagents (PEG and protamine) instead of expensive ultracentrifugation equipment. The precipitation method can be performed with simple mixing and low-speed centrifugation, eliminating the need for costly ultracentrifuges and reducing device complexity.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Loss of time

If polymeric precipitation with PEG is used to isolate EVs, then isolation speed is improved, but EV recovery efficiency from small samples is insufficient

Engineering Contradiction:
Improveisolation speedVSAvoidEV recovery amount
Core Design Contradiction:
Loss of timeVSQuantity of substance

Solution Approach 1:

The patent uses a composite precipitation system combining PEG (polyethylene glycol) and protamine. PEG forms the mesh-like net structure that embeds EVs, while protamine enhances the precipitation efficiency and EV recovery. This composite approach maintains the speed advantage of polymeric precipitation while significantly improving EV recovery from small biological samples.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

Protamine acts as an intermediary that enhances the interaction between PEG and EVs. The polycationic nature of protamine facilitates binding to the negatively charged EV surface, improving precipitation efficiency and recovery amount without sacrificing isolation speed.

Inventive Principle:
Principle #24Intermediary (Mediator)

4Loss of time

If conventional polymeric precipitation is used to isolate EVs, then isolation speed is improved, but contamination and loss of biological activity occur

Engineering Contradiction:
Improveisolation speedVSAvoidcontamination and biological activity loss
Core Design Contradiction:
Loss of timeVSObject-generated harmful factors

Solution Approach 1:

The patent uses a composite precipitation system combining PEG (polyethylene glycol) and protamine. PEG forms the mesh-like net structure that embeds EVs, while protamine enhances the precipitation efficiency and EV recovery. This composite approach maintains the speed advantage of polymeric precipitation while significantly improving EV recovery from small biological samples.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention changes the isolation parameters from mechanical force-based (centrifugal force, g force, rotor type) to chemical composition-based (PEG concentration, protamine concentration, molecular weight). This parameter change allows efficient EV isolation without the damaging effects of ultracentrifugation.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method effectively isolates EVs from small biological samples with improved integrity and biological activity, avoiding the need for expensive equipment and reducing contamination, while maintaining RNA recovery and exosomal marker expression.

Implementation Method 1

The polymeric precipitation methods are based on the formation of a mesh-like net, which embeds EVs with a size ranging from 60 to 180 nm

Methodology Applied
Scientific EffectPolymeric precipitation: Precipitation

Implementation Method 2

mixing the biological fluid sample with a polycationic substance and an extracellular matrix forming polymer, incubating the resulting mixture, thereby achieving precipitation of EVs

Methodology Applied
Scientific EffectElectrostatic interaction: Ion Repulsion/Attraction

Data Source

PatentUS11484816B2Isolation of extracellular vesicles (EVs) from biological fluid samples
Publication Date: 2022.11.01 UNICYTE EV AG
  • US11484816B2 patent drawing
  • US11484816B2 patent drawing
  • US11484816B2 patent drawing

AI summary

The invention relates to compositions and methods for isolating extracellular vesicles (EVs) from a biological fluid sample. The compositions and methods of the invention are based on the combination of a polycation with an extracellular matrix forming polymer. Extracellular vesicles (EVs) are isolated from biological fluids such as blood, serum, plasma, saliva, urine or cerebrospinal fluid, or from the conditioned medium of a cell culture, such as an adult stem cell culture. The use of the isolation methods and compositions of the invention results in a higher EVs recovery, enrichment in exosomes, simplicity, cost-effectiveness, and in the isolation of EVs that retain their biological activities in vitro.